Naveed Ahmed | Infectious Diseases | Best Researcher Award

Published on by Chemistry Awards

Assist. Prof. Dr. Naveed Ahmed | Infectious Diseases | Best Researcher Award

Assistant Professor at University of Tabuk | Saudi Arabia

Dr. Naveed Ahmed is a Medical Microbiologist and Assistant Professor at the University of Tabuk, Saudi Arabia. He holds a Ph.D. in Medical Microbiology from Universiti Sains Malaysia and has made impactful contributions in infectious diseases, cancer immunology, and antimicrobial resistance. With extensive experience in diagnostics, clinical microbiology, and translational research, Dr. Ahmed has been actively involved in national and international research collaborations. He has received numerous awards including the Best PhD Thesis Nomination, Sanggar Sanjung Awards, and Best Presenter accolades. He is a registered scientist in the UK, a fellow of The Global Health Network, and an active member of prestigious societies such as the Royal Society of Biology and Human Cell Atlas. His dynamic work in diagnostics and immunotherapy underscores his commitment to global public health and biomedical innovation.

Professional Profile

Google Scholar

Orcid

Education 

Dr. Naveed Ahmed earned his Doctor of Philosophy in Medical Microbiology from Universiti Sains Malaysia, one of Asia’s top universities, where he conducted translational research on Epstein-Barr virus and immunotherapy. He previously obtained an M.Sc. in Microbiology from the University of Central Punjab and a BS (Honors) in Medical Laboratory Technology from the University of the Punjab, Lahore. His academic journey reflects a consistent focus on infectious diseases, molecular microbiology, and clinical diagnostics. He has demonstrated academic excellence throughout, receiving multiple honors, scholarships, and research funding support. His doctoral research involved grant writing, protocol development, ethical approvals, and advanced laboratory techniques. With a solid foundation in research methodology, data analysis, and laboratory practices, Dr. Ahmed’s academic record not only showcases theoretical knowledge but also hands-on expertise across diagnostic microbiology, virology, and translational immunology.

Experience

Dr. Naveed Ahmed is currently serving as Assistant Professor at the University of Tabuk, Saudi Arabia, where he teaches undergraduate courses, participates in curriculum design, and contributes to academic quality assurance. Prior to this, he worked as a Graduate Research Assistant at Universiti Sains Malaysia , engaging in high-level research, grant writing, and regulatory submissions, including patents and ethical approvals. He also served as a Laboratory Technologist in Microbiology at the Pakistan Kidney and Liver Institute, and as a Supervisor at Chughtai Lab, overseeing ISO implementation, staff training, and quality control. He has additional teaching experience as a visiting lecturer at multiple universities in Pakistan. His professional journey spans academia, diagnostics, and research management, with strengths in infectious disease diagnosis, molecular techniques, antimicrobial stewardship, and academic mentorship. Dr. Ahmed has successfully bridged the gap between clinical practice and translational research throughout his career.

Awards 

Dr. Naveed Ahmed has been recognized for excellence throughout his academic and research career. He received the “Graduate on Time” Award and was nominated for the Best PhD Thesis Award by Universiti Sains Malaysia in 2024. He was also honored with the prestigious Sanggar Sanjung Award in both 2021 and 2022 for outstanding publication-based achievements. In 2023, he earned 2nd Place in Oral Presentation and the Young Investigator Award at the Regional Conference on Molecular Medicine. His communication and academic engagement have also been rewarded through accolades such as Best Oral Presenter (Journal Club, 2022) and Best Poster Presentation at the 17th Annual Conference of Medical Microbiology and Infectious Diseases Society of Pakistan. Furthermore, he has secured competitive research funding and was selected under the USM Research Assistance Scheme. These awards highlight his dedication to research innovation, academic excellence, and scientific leadership in microbiology and immunology.

Research Interests 

Dr. Naveed Ahmed’s research interests span a wide array of fields in medical microbiology and translational medicine. His work focuses on infectious diseases, antimicrobial resistance, vaccine design, cancer immunology, and rapid diagnostic methods for tropical infections. He has extensively studied Epstein-Barr Virus (EBV), particularly its oncogenic mechanisms in nasopharyngeal carcinoma, and explored immune checkpoint pathways relevant to cancer immunotherapy. Dr. Ahmed is also involved in the development and validation of point-of-care diagnostic tools and rapid antigen assays for mosquito-borne and respiratory viruses. His proficiency in bioinformatics, immunoinformatics, and systematic review methodologies supports his multidisciplinary approach. His scientific contributions include high-impact publications, intellectual property registrations, and collaboration with international research entities and biotech firms. Driven by a vision of innovation, his research aims to bridge diagnostic gaps, enhance global health surveillance, and inform public health policy. He continues to explore the intersection of microbiology, nanomedicine, and personalized therapy.

Publication Top Notes

  1. Title: Application of artificial intelligence in combating high antimicrobial resistance rates
    Year: 2022
    Citations: 112

  2. Title: Synthesis of Silver Nanoparticles from Extracts of Wild Ginger (Zingiber zerumbet) with Antibacterial Activity against Selective Multidrug Resistant Oral Bacteria
    Year: 2022
    Citations: 77

  3. Title: High-dose vitamin C for cancer therapy
    Year: 2022
    Citations: 75

  4. Title: Self-medication as an important risk factor for antibiotic resistance: a multi-institutional survey among students
    Year: 2022
    Citations: 68

  5. Title: The Antimicrobial Efficacy Against Selective Oral Microbes, Antioxidant Activity and Preliminary Phytochemical Screening of Zingiber officinale
    Year: 2022
    Citations: 66

  6. Title: Clinical manifestation, transmission, pathogenesis, and diagnosis of monkeypox virus: a comprehensive review
    Year: 2023
    Citations: 56

  7. Title: The usage of antibiotics by COVID-19 patients with comorbidities: the risk of increased antimicrobial resistance
    Year: 2021
    Citations: 53

  8. Title: Smoking a dangerous addiction: a systematic review on an underrated risk factor for oral diseases
    Year: 2021
    Citations: 50

  9. Title: Evaluation of bi-lateral co-infections and antibiotic resistance rates among COVID-19 patients
    Year: 2022
    Citations: 46

  10. Title: Synthesis, Characterization and antimicrobial activity of Bacillus subtilis-derived silver nanoparticles against multidrug-resistant bacteria
    Year: 2020
    Citations: 46

Conclusion 

Dr. Naveed Ahmed exemplifies a modern scientist whose career integrates academia, clinical diagnostics, and innovative research. With a diverse educational background and professional trajectory across Pakistan, Malaysia, and Saudi Arabia, he has established himself as a dedicated researcher and educator in medical microbiology and infectious diseases. His accolades, scholarly output, and scientific leadership reflect his commitment to advancing global health through research and education. He brings a unique perspective to teaching, combining rigorous scientific training with real-world clinical insight. Dr. Ahmed’s current and future endeavors aim to drive innovation in microbial diagnostics, immunotherapy, and antimicrobial resistance mitigation. His active roles in international collaborations and professional societies further reinforce his influence in the global scientific community. As he continues his academic and research journey, Dr. Ahmed remains focused on contributing meaningfully to public health solutions, empowering young scientists, and promoting evidence-based practices in microbiology and medicine.

Assist. Prof. Dr. Changtong YANG | Medicinal Chemistry | Best Researcher Award

Published on by Chemistry Awards

Assist. Prof. Dr. Changtong YANG | Medicinal Chemistry | Best Researcher Award

Assist. Prof. Dr. Changtong YANG , Medicinal Chemistry,  Radiochemist/Chemist at Singapore General Hospital, Singapore

Dr. Chang-Tong Yang is a renowned radiochemist based in Singapore, specializing in radiopharmaceuticals and molecular imaging. He currently serves as an Assistant Professor in the Radiological Science Academic Clinical Programme at Duke-NUS Medical School and as a Radiochemist at Singapore General Hospital. With over two decades of experience, Dr. Yang has made significant contributions to the development of nuclear imaging probes and radiolabeled therapeutics. His research career spans prestigious institutions, including Nanyang Technological University and A*STAR. Dr. Yang is internationally recognized for advancing nanomaterial probes and novel radiolabeling strategies. He has authored impactful publications in top-tier journals, reflecting his innovation in theranostics, radiochemistry, and nanomedicine. With a strong background in academic and clinical research, Dr. Yang continues to shape the future of molecular imaging for personalized medicine. His global education and interdisciplinary expertise make him a leading figure in translational radiochemistry research.

Professional Profile : 

Orcid

Scopus 

Summary of Suitability for Award:

Dr. Chang-Tong Yang exemplifies the qualities of a “Best Researcher Award” recipient. His innovative contributions to radiochemistry and molecular imaging, combined with a strong publication record, interdisciplinary leadership, and global training, establish him as a trailblazer in translational medical research. His work is not only scientifically rigorous but also clinically impactful, directly advancing the field of nuclear medicine. Therefore, he is highly recommended for recognition as a top-tier researcher deserving of this award.

🎓Education:

Dr. Chang-Tong Yang received his Ph.D. in Chemistry from the National University of Singapore (1998–2002), where he laid the foundation for his career in radiochemistry. He further enhanced his expertise with postdoctoral fellowships at three prestigious U.S. institutions: University of Iowa (2003–2005), University of Michigan (2005–2006), and Purdue University (2006–2007), focusing on chemistry and health sciences. These formative years provided Dr. Yang with a multidisciplinary perspective in synthetic chemistry, radiopharmaceutical development, and imaging sciences. His international training exposed him to cutting-edge methodologies and collaborative projects across biomedical research, which he has since translated into innovative imaging solutions. The combination of rigorous education and hands-on research across these top institutions shaped his ability to bridge fundamental science with clinical applications, particularly in nuclear medicine and molecular imaging.

🏢Work Experience:

Dr. Chang-Tong Yang brings extensive professional experience across both academic and clinical research settings. He is currently an Assistant Professor at Duke-NUS Medical School (2020–present) under the Radiological Science ACP, focusing on radiopharmaceutical sciences. Concurrently, he serves as a Radiochemist at Singapore General Hospital (2018–present) in the Department of Nuclear Medicine & Molecular Imaging, where he translates research into clinical practice. Prior to that, he worked as a Senior Scientist at Nanyang Technological University (2014–2018), contributing to molecular imaging initiatives within the Lee Kong Chian School of Medicine. He also held a Senior Scientist role at A*STAR’s Singapore Bio-Imaging Consortium (2007–2014), leading various radiochemistry research programs. Across these roles, Dr. Yang has developed and validated imaging agents, optimized radiolabeling techniques, and led translational studies that impact diagnostic imaging and therapeutic strategies. His multidisciplinary engagements underscore his pivotal role in bridging chemistry and medicine.

🏅Awards: 

While specific awards are not listed in the available data, Dr. Chang-Tong Yang’s extensive contributions to radiopharmaceuticals and molecular imaging reflect a highly respected and impactful career. His appointments at top institutions such as Duke-NUS, A*STAR, and Singapore General Hospital indicate peer recognition and institutional trust. His publications in reputed journals such as Molecules, Nanomaterials, and Drug Discovery Today highlight his standing in the scientific community. His ongoing leadership roles and collaboration with clinicians further underscore professional acknowledgment of his expertise. Dr. Yang’s selection for multiple postdoctoral positions at prestigious U.S. institutions—University of Iowa, University of Michigan, and Purdue University—suggests early recognition of his academic promise. His interdisciplinary contributions to nuclear medicine, nanotechnology, and molecular imaging may have earned him internal institutional awards, research grants, and invitations to present at scientific forums, which commonly accompany such roles.

🔬Research Focus:

Dr. Chang-Tong Yang’s research is centered on radiopharmaceutical science, with a strong emphasis on the development of molecular imaging probes and radiolabeled nanomaterials for diagnostic and therapeutic applications. His expertise lies in designing novel radioisotope-labeled compounds for use in nuclear medicine imaging techniques such as PET and SPECT, targeting cancer and other pathological conditions. He is particularly interested in enhancing the in vivo behavior of nanomaterial-based agents, improving tumor targeting, retention, and safety. Dr. Yang also explores the biocompatibility and stability of these probes, including how formulation and labeling protocols influence their function. His translational work bridges laboratory innovations with clinical imaging requirements, enabling personalized diagnostics and theranostic approaches. Furthermore, he investigates radiochemical compatibility in clinical settings, such as the mixing of imaging agents with contrast media, which supports safe and effective imaging protocols. His work integrates chemistry, imaging, and clinical practice seamlessly.

Publication Top Notes:

1. pH-Induced In Situ Aggregation of Cu₂₋ₓSe-POED with Extended Tumor Retention for Enhanced Chemodynamic/Photothermal Therapy

2. Standard Radio-Iodine Labeling Protocols Impaired the Functional Integrity of Mesenchymal Stem/Stromal Cell Exosomes

3. Radiolabeled Liposomes for Nuclear Imaging Probes

4. Radiochemical Feasibility of Mixing of 99mTc-MAA and 90Y-Microspheres with Omnipaque Contrast

5. Nanomaterial Probes for Nuclear Imaging

6. Positron Emission Tomographic Imaging in Drug Discovery

7. An In Vivo Study of a Rat Fluid-Percussion-Induced Traumatic Brain Injury Model with [11C]PBR28 and [18F]flumazenil PET Imaging

8. Gadolinium-Based Bimodal Probes to Enhance T1-Weighted Magnetic Resonance/Optical Imaging

9. Activatable Cell-Penetrating Peptide Conjugated Polymeric Nanoparticles with Gd-Chelation and Aggregation-Induced Emission for Bimodal MR and Fluorescence Imaging of Tumors

10. Dealing with PET Radiometabolites

11. PET-MR and SPECT-MR Multimodality Probes

 

Assoc. Prof. Dr. Ningbo Li | Medicinal Chemistry | Best Researcher Award

Published on by Chemistry Awards

Assoc. Prof. Dr. Ningbo Li | Medicinal Chemistry | Best Researcher Award

Assoc. Prof. Dr. Ningbo Li , Medicinal Chemistry , Shanxi Medical University, China

Dr. Ningbo Li is an accomplished Associate Professor at the School of Basic Medical Sciences, Shanxi Medical University, with a strong academic foundation and a passion for cancer research. With a doctorate in Organic Chemistry from Hunan University, Dr. Li has built a reputable career in green synthesis, targeted nano-drug delivery systems, and near-infrared fluorescent probes molecule for cancer diagnostics and therapy. He has led over 10 national and provincial research projects, published 46 SCI-indexed papers, and holds 5 authorized patents. Dr. Li also contributes to academia through textbooks and serves as a Young Editorial Board Member of Journal of Xiangtan University. His collaborations span leading institutions like Hunan University and Nankai University. With 863 citations and rising influence, Dr. Li is committed to pioneering innovative, low-toxicity cancer therapeutics and translating lab findings into clinical advances.

Professional Profile : 

Orcid   

Scopus 

Summary of Suitability for Award:

Dr. Ningbo Li, Associate Professor at Shanxi Medical University, has demonstrated exceptional research productivity and innovation in the fields of organic chemistry, nanomedicine, and cancer therapeutics. With over 50 SCI-indexed publications, 5 authorized patents, and leadership on more than 10 national and provincial-level research projects, Dr. Li has made significant contributions to targeted cancer treatment and green synthesis of anti-tumor agents. His pioneering work on magnetic nano-drug delivery systems and near-infrared fluorescent probes molecule showcases translational potential for clinical applications in oncology. Furthermore, his involvement in academic book publications, editorial duties, and inter-institutional collaborations reflects both leadership and scholarly impact. With a citation index of 863 and consistent innovation through funded research, Dr. Li exemplifies the qualities of a top-tier researcher. Dr. Ningbo Li is highly suitable for the “Best Researcher Award”, as he meets and exceeds the criteria in terms of research excellence, innovation, scientific impact, and societal relevance. His dedication to advancing cancer research through interdisciplinary chemistry and his strong track record in publications, patents, and funded projects make him a deserving and outstanding candidate for this prestigious recognition

🎓Education:

Dr. Ningbo Li’s academic journey began with a Bachelor’s degree in Chemistry from Shanxi Datong University (2005–2009). He pursued his postgraduate studies at Hunan University, earning a Master’s degree (2009–2012) and subsequently a Ph.D. in Organic Chemistry (2012–2015). His academic training emphasized organometallic chemistry, chiral complex synthesis, and catalysis, laying the groundwork for his future research in drug development and nanomedicine. During his doctoral studies, Dr. Li specialized in chiral Lewis acids, exploring their role in asymmetric synthesis—an area critical to pharmaceutical innovation. His graduate work was pivotal in shaping his later focus on bio-compatible metal complexes and tumor-targeted drug delivery platforms. The integration of organic synthesis with biomedical applications became a hallmark of his educational path, culminating in a multidisciplinary approach that bridges chemistry, nanotechnology, and medical science.

🏢Work Experience:

Dr. Ningbo Li began his academic career as a Lecturer (2015–2018) at the School of Basic Medical Sciences, Shanxi Medical University, where he conducted interdisciplinary research and mentored students. In December 2018, he was promoted to Associate Professor, reflecting his growing contributions to research and teaching. With over a decade in academia, he has supervised numerous graduate projects and continues to develop innovative strategies for targeted cancer therapy using nanomaterials and fluorescent probes. Dr. Li has consistently received competitive research funding from the National Natural Science Foundation of China and the Shanxi Provincial Science Foundations. He also actively contributes to national teaching excellence through authorship in leading organic chemistry textbooks. His dedication to both scientific advancement and student development underscores a career that blends high-impact research with academic leadership in medical and chemical sciences.

🏅Awards: 

While specific named awards are not detailed, Dr. Ningbo Li’s academic honors are evident through his prestigious research grants, editorial board appointment, and book contributions. He is the Principal Investigator for multiple national-level research projects, including NSFC Young Scholar Awards, which are highly competitive and indicative of early-career excellence. His appointment as a Young Editorial Board Member of the Journal of Xiangtan University (Natural Science Edition) further reflects his scientific influence and peer recognition. Dr. Li’s patents on chiral zirconium and titanium complexes also highlight his innovative contributions to chemical synthesis. Moreover, his extensive publishing record and the high citation index (863) attest to the impact of his research in organic and medicinal chemistry. Through his involvement in writing authoritative textbooks used in higher education, Dr. Li has contributed significantly to the academic development of students and educators in China.

🔬Research Focus:

Dr. Ningbo Li’s research is centered on the interdisciplinary interface of organic chemistry, nanotechnology, and cancer therapeutics, with a strong emphasis on green and sustainable chemistry. His primary focus lies in the design and synthesis of functionalized magnetic nanocomposites and near-infrared fluorescent probe molecules for the precise diagnosis and targeted treatment of malignant tumors. By engineering magnetic-targeted nano-drug delivery systems, his team aims to achieve site-specific drug accumulation, minimizing systemic toxicity and enhancing therapeutic efficacy. Another key area involves the green synthesis of novel bioactive compounds, particularly chiral organometallic complexes, which exhibit promising anti-tumor properties. His group also explores chiral Lewis acids as catalysts in asymmetric reactions, crucial for the development of structurally complex pharmaceuticals. Dr. Li’s research is highly translational, striving to bridge the gap between bench and bedside by accelerating the clinical application of biocompatible, efficient, and low-toxicity cancer therapeutics rooted in advanced chemical innovation.

Publication Top Notes:

1. g-C₃N₄-Based Heterogeneous Photocatalyzed Synthesis and Evaluation of Antitumor Activities of Fluoroalkylated 4H-Pyrido[1,2-a]pyrimidin-4-ones

2. Magnetic Nanocarriers for pH/GSH/NIR Triple-Responsive Drug Release and Synergistic Therapy in Tumor Cells

3. GSH-Responsive Magnetic Mesoporous Silica Nanoparticles for Efficient Controlled Drug Delivery in Tumor Cells

 

​

Asmaa Hamouda | Medicinal Chemistry | Best Researcher Award

Published on by Chemistry Awards

Dr. Asmaa Hamouda | Medicinal Chemistry | Best Researcher Award

Doctorate at Alexandria University, Egypt

Asmaa F. Hamouda is an accomplished biochemist with over a decade of experience in teaching and research, focusing on medical biochemistry and lifestyle-related disorders. A breast cancer survivor, she is deeply committed to patient education and support, particularly in disease management. Based in Egypt, Asmaa has authored 25 books and published 30 scientific papers, making significant contributions to her field. Her diverse experiences include roles at prestigious universities and clinical settings.

Author Metrics

Scopus Profile

ORCID Profile

Google Scholar Profile

Asmaa has achieved considerable recognition in the academic community, evidenced by a robust citation record on platforms such as Google Scholar. Her research impact is reflected in her numerous publications and her active engagement in scientific discourse, highlighting the significance of her contributions to biochemistry and nutrition.

  • Citations: 48
  • Documents: 7
  • h-index: 4

Education

Asmaa holds a PhD in Biochemistry from Alexandria University, earned in January 2013, where she graduated with distinction. She also completed her Master’s degree in Biochemistry in October 2007 and her Bachelor of Science in Biochemistry/Chemistry in May 2003, both from the same institution. In 2021, she further enhanced her expertise by obtaining a professional certification in Functional Medicine and Nutrition.

Research Focus

Her research primarily investigates the biochemical mechanisms underlying lifestyle diseases and the role of nutrition in health management. Asmaa is particularly interested in exploring natural compounds for disease prevention and treatment, aiming to bridge the gap between biochemistry and practical health solutions.

Professional Journey

Asmaa began her career as a demonstrator at Alexandria University, gradually advancing to positions such as lecturer and assistant professor at universities in Saudi Arabia. Currently, she serves as a nutrition advisor, leveraging her academic expertise to support patients in managing their health through tailored nutritional strategies.

Honors & Awards

Throughout her career, Asmaa has received numerous accolades for her contributions to teaching and research. Her work has been recognized at various international conferences, where she has been invited to speak and present, underscoring her influence and leadership in the field of biochemistry.

Publications Noted & Contributions

Asmaa has authored a variety of influential publications in reputable scientific journals, with key studies focusing on the biochemical effects of natural extracts. Her research on the therapeutic potential of compounds like pomegranate and avocado has drawn attention, showcasing innovative approaches to managing chronic diseases.

Investigating Grape Seed Extract as a Natural Antibacterial Agent for Water Disinfection in Saudi Arabia: A Pilot Chemical, Phytochemical, Heavy-Metal, Mineral, and CB-Dock Study Employing Water and Urine Samples

Identification of Effective Anti-HCV and Anti-HIV Royal Jelly Constituents and Their Acute Toxicity Evaluation in Albino Rats

  • Journal: Food and Chemical Toxicology
  • Date: 2023-12
  • DOI: 10.1016/j.fct.2023.114170
  • Contributors: Noha H. Habashy, Asmaa F. Hamouda, Marwa M. Abu Serie

A Bio-Indicator Pilot Study Screening Selected Heavy Metals in Female Hair, Nails, and Serum from Lifestyle Cosmetic, Canned Food, and Manufactured Drink Choices

Biochemical Pilot Study on Effects of Pomegranate Seed Oil Extract and Cosmetic Cream on Neurologically Mediated Skin Inflammation in Animals and Humans: A Comparative Observational Study

A Pilot Study of the Amelioration of Avocado Seed Oil in Obese Female Rats Induced by Carbon Tetrachloride and Alloxan Monohydrate

  • Journal: Journal of Drug and Alcohol Research
  • Date: 2022
  • Contributors: Asmaa Fathi Hamouda

 Research Timeline

Her research journey spans several significant projects, from her doctoral studies to her ongoing work as a nutrition advisor. Asmaa has consistently contributed to the academic literature, providing valuable insights into the role of biochemistry in health and disease management.

Collaborations and Projects

Asmaa has engaged in numerous collaborations with institutions and researchers across the globe. Her participation in international conferences has fostered partnerships in the fields of biochemistry and nutrition, enhancing the impact and reach of her research efforts.

Conclusion

Dr. Asmaa Hamouda exemplifies excellence in the field of medicinal chemistry and biochemistry. Her robust publication record, innovative research, and commitment to patient education highlight her as a leading figure in the academic community. While she has achieved significant recognition, focusing on collaboration, visibility, and public engagement can further enhance her impact. With her dedication and expertise, Asmaa is well-positioned to continue making meaningful contributions to health management and disease prevention.